Different people experiencing medical care

There is no single way people enter the rooms of terminal cancer care. The diagnosis may be shared in one sentence, in one scan report, in one quiet phone call, but what follows fractures into a thousand different languages depending on who is holding the clipboard, who is asking the questions, and who is trying to make meaning out of a life that has just been re-measured in months instead of years.

In the world I and others living with Stage IV Metastatic Breast Cancer (MBC) inhabit, the edges are already visible. Nothing is softened by abstraction. Everything is already metabolized through time: what is left of it, what is being spent, what is being negotiated with every appointment. And in that space, people do not just receive care. They interact with it like they interact with any system they’ve learned to survive: through their profession, their instincts, their training, their distrust, their hope.

The teacher arrives first as a translator.

They sit in oncology appointments with a pen in hand, not because they believe they will be tested, but because they have spent a life converting complexity into something others can hold. They underline words like progression, line of therapy, palliative intent. They ask clarifying questions not only for themselves, but for the future students who will ask them—what did it feel like, what did it mean, what happened next?

Teachers tend to make schedules out of chaos. Treatment calendars become lesson plans. Blood draws become attendance. They try to sequence grief into something that can be reviewed later, as if understanding will eventually soften the blow.

The lawyer enters differently. The lawyer listens for language that can be held accountable.

Consent forms are not paperwork; they are contracts. Risks are not statistics; they are liabilities. The lawyer asks what is guaranteed, what is speculative, what is standard of care, what is deviation. They are not being difficult. They are trying to locate certainty in a system that only offers probabilities.

When things go wrong, the lawyer already knows how testimony is built. They understand how narratives shift under pressure. They are often the first to notice when “we will do everything” quietly becomes “there is nothing more we can do.”

An engineer approaches health like a system, looking for faults and assigning responsibility.

When suddenly your body becomes the system and the healthcare system becomes the machine you have to navigate to keep that body functioning for as long as possible, an engineer applies they know how to do. Build spreadsheets, begin tracking labs and scans and medications. Read the papers, learn the vocabulary to understand which results matter and which ones are noise. You start treating appointments like engineering meetings because, frankly, the stakes are considerably higher than most engineering meetings. And maybe there is some comfort in believing that if you can understand enough of the system, you can find the failure before it finds you.

Except cancer is not a machine, and healthcare is not a well-designed system. There is missing data, conflicting information, incompatible software, delays, insurance companies making decisions without understanding the patient, specialists who don’t communicate with each other, and people who are perfectly comfortable saying, “That’s just the way we do it,” when the obvious follow-up question is, “Yes, but why?” An engineer may initially believe that enough information will eventually produce the right answer, that every problem has a root cause and every failure has a fix. Terminal cancer is a brutal teacher because sometimes you can understand the system perfectly and still lose. Sometimes the scan is worse. Sometimes the drug stops working. Sometimes the clinical trial isn’t available, the insurance company says no, or the treatment you need isn’t the treatment you can tolerate. And eventually the work shifts from trying to control the outcome to making damn sure the decisions are informed, the assumptions are challenged, and the people making them understand that there is a human being attached to every data point. Because this isn’t quality control. This isn’t troubleshooting. This is a life.

The banker sits across from the same information and converts it into time as capital.

They think in allocation. Energy is a portfolio. Treatment is an investment strategy with diminishing returns and shifting risk tolerance. They ask about quality-adjusted life years even when no one uses that phrase aloud. They are not cold; they are trained to see constraint as structure.

They may ask, if this buys me six more months, what is the cost in side effects, in hospital time, in cognitive fog? They are accustomed to trade-offs that do not pretend to be anything else. And still, something breaks the model. Because no financial instrument accounts for the experience of nausea at 3 a.m. when everything is closed and the future feels like a room without doors.

The project manager tries to run the illness like a system that can be optimized.

They build spreadsheets for medications, color-coded calendars for infusion days, contingency plans for scan delays. They identify bottlenecks in care delivery. They ask who owns what decision. They create Slack channels for family communication because coordination failure is just another type of risk. There is dignity in this approach. It is not denial. It is the belief that if enough variables are named, chaos will behave.

But cancer does not respect dependencies. It does not stay in scope. It does not adhere to sprint boundaries or milestone reviews. And still, the project manager keeps building structure around something that refuses to stabilize, because structure is its own kind of survival.

The scientist enters the room already split into two selves: observer and participant.

They want the data. They want the trial eligibility criteria. They want the Kaplan-Meier curves that show what happens to people like them in aggregate. They understand significance, confidence intervals, hazard ratios. They know what it means to be a tail end of a distribution. But being inside the distribution is different from studying it. There is a moment when statistical survival becomes personal survival, and the language stops protecting and starts exposing.

The scientist still asks better questions than most. They ask about mechanisms, resistance patterns, second-line options. But late at night, the curiosity shifts. Not what works in general—but what is happening in me, right now, that is not captured in any paper.

The health care worker carries a different burden. They recognize the system from both sides of the bed.

They know what is being left unsaid in the pauses. They know which reassurances are ritual and which are real. They also know too much. They have seen trajectories that do not make it into brochures. They have held hands when medicine runs out of vocabulary.

Because of this, they may become either the most compliant or the most resistant patient. Some trust the system deeply, having seen its intent up close. Others interrogate every step, having seen its failure modes. They understand that care is not a feeling. It is a series of constrained decisions made by exhausted humans under imperfect conditions.

An artist arrives looking for meaning, because they are accustomed to looking closely.

They notice the pauses before a doctor answers. The difference between we can and we should. The way a physician studies a scan before looking up from the screen. An artist is trained, in a sense, to resist the first interpretation. To turn the object over. To look at it from another angle. Cancer demands the same discipline. Every decision becomes an exercise in perspective, while the medical system wants decisions. The artist wants to understand the decision before making it. That can be both a gift and a burden. There is a tendency in medicine to move forward because there is always another test, another drug, another specialist, another possibility. But an artist knows that adding more to a canvas does not necessarily make the painting better. Sometimes the harder question is what to leave out.

So the conversations with doctors become less about surrendering judgment and more about collaboration—bringing expertise, skepticism, intuition, and lived experience into the same room. The artist learns when to trust the oncologist and when to ask one more question. Learns that statistics describe populations, not individual lives. Learns that hope and realism are not opposites. And perhaps most importantly, learns that navigating terminal cancer is itself an act of authorship: deciding which risks are worth taking, which possibilities are worth pursuing, and what kind of life the treatment is meant to preserve. The doctors may know the medicine. The artist still has to decide what the medicine is for.

And then there are those who do not fit cleanly into any of these roles, or who contain all of them at once. The same person can be lawyer in the morning, teacher in the afternoon, project manager at night when sleep will not come. Identity becomes rotational. No single framework holds long enough to explain how to live inside the diagnosis.

What unites them is not personality, it is friction. Every person encounters the same core tension: how much to resist the “standard of care,” how much to accept, how to speak to time when time is no longer neutral. Some approach care as a system to be mastered. Some approach it as a narrative to be understood. Some approach it as a negotiation with an ending that will not negotiate back. And underneath all of it is the body, no longer abstract, no longer deferred. The body that once served these roles without being noticed now becomes the central meeting point for every decision.

There is no illusion that this is clean. There is only the attempt to remain honest inside complexity; to see clearly without demanding that clarity be comforting. In the clinic, these identities briefly collapse into something simpler: a person in a chair, a clinician across from them, and a shared awareness that something irreversible has already happened. But even there, the old ways return. A question phrased like cross-examination. A request for data. A plan drawn in bullet points. A metaphor offered where numbers fail.

Terminal cancer care is sometimes described as a journey (you can read more about what I think about that term here), but that metaphor is too smooth. It implies directionality. What it resembles more is a field where every person brings their training and instinct to bear on terrain that does not care what they know. And still, people try. They try to organize, to understand, to question, to build, to translate, because that is what they have always done.

And because even when outcomes are no longer negotiable, the way a person moves through the remaining structure of care still matters.

As we start 2026 Breast Cancer Awareness Month, please be on the lookout for PinkWashing and mark your calendars for the #LightUpMBC live show on October 13th, the ONE day all October set aside for those of us living with MBC.